CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-label, Multi-centre Study of the Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine (ProQuad®) Manufactured With Recombinant Human Albumin (rHA) When Administered to Children in Their Second Year of Life

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00560755
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:46.690393+00:00
Published At: 2017-10-17T00:00:00+00:00
Record Updated At: 2017-10-17
Results Posted At: 2017-10-17
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Measles", "Mumps", "Rubella", "Varicella"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-10-17"
protocolSection.identificationModule.nctId: "NCT00560755"
protocolSection.identificationModule.officialTitle: "An Open-label, Multi-centre Study of the Safety of a 2-dose Regimen of a Combined Measles, Mumps, Rubella and Varicella Live Vaccine (ProQuad\u00ae) Manufactured With Recombinant Human Albumin (rHA) When Administered to Children in Their Second Year of Life"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2017-10-17"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.